| Praxis Precision Medicines, Inc. | 88,781 | US$29.7M | 18.1% |
| Maplight Therapeutics, Inc. | 493K | US$17.7M | 10.8% |
| Sutro Biopharma, Inc. | 512K | US$17M | 10.4% |
| Immix Biopharma, Inc. | 1.08M | US$11.2M | 6.8% |
| Protara Therapeutics, Inc. | 2.84M | US$10.9M | 6.6% |
| Abivax Sa | 65,630 | US$8.75M | 5.3% |
| Tenax Therapeutics, Inc. | 550K | US$8M | 4.9% |
| Anteris Technologies Global Corp. | 700K | US$6.89M | 4.2% |
| Edesa Biotech, Inc. | 828K | US$6.73M | 4.1% |
| Evommune, Inc. | 451K | US$6M | 3.7% |
| Avalo Therapeutics, Inc. | 324K | US$6M | 3.7% |
| Xencor, Inc. | 255K | US$4.11M | 2.5% |
| Rezolute, Inc. | 750K | US$3.9M | 2.4% |
| Heron Therapeutics, Inc. | 8.75M | US$3.74M | 2.3% |
| Verrica Pharmaceuticals Inc. | 472K | US$2.89M | 1.8% |
| C4 Therapeutics, Inc. | 570K | US$2.66M | 1.6% |
| Eupraxia Pharmaceuticals, Inc. | 352K | US$2.33M | 1.4% |
| Adma Biologics Inc | 250K | US$2.09M | 1.3% |
| Rein Therapeutics, Inc. | 1.7M | US$1.77M | 1.1% |
| Lyell Immunopharma, Inc. | 105K | US$1.48M | 0.90% |
| Profound Medical Corp | 170K | US$1.13M | 0.69% |
| Jasper Therapeutics, Inc. | 2.67M | US$1.12M | 0.68% |
| Protagonist Therapeutics, Inc. | 3,700 | US$454K | 0.28% |
| Cytomx Therapeutics, Inc. | 120K | US$450K | 0.27% |
| Neumora Therapeutics, Inc. | 230K | US$391K | 0.24% |
| Nurix Therapeutics, Inc. | 16,000 | US$388K | 0.24% |
| Ovid Therapeutics Inc. | 130K | US$350K | 0.21% |
| Precision Biosciences, Inc. | 40,000 | US$314K | 0.19% |
| Mineralys Therapeutics, Inc. | 11,000 | US$297K | 0.18% |
| Macrogenics, Inc. | 60,000 | US$277K | 0.17% |
| Corbus Pharmaceuticals Holdings, Inc. | 26,000 | US$244K | 0.15% |
| Artiva Biotherapeutics, Inc. | 25,000 | US$243K | 0.15% |
| Replimune Group, Inc. | 20,000 | US$221K | 0.13% |
| Syndax Pharmaceuticals, Inc. | 10,000 | US$219K | 0.13% |
| Immunome, Inc. | 10,000 | US$212K | 0.13% |
| Tectonic Therapeutic, Inc. | 6,000 | US$206K | 0.13% |
| Rocket Pharmaceuticals, Inc. | 60,000 | US$205K | 0.12% |
| Karyopharm Therapeutics Inc. | 20,000 | US$195K | 0.12% |
| An2 Therapeutics, Inc. | 40,000 | US$194K | 0.12% |
| Viridian Therapeutics, Inc. | 10,000 | US$184K | 0.11% |
| Xilio Therapeutics, Inc. | 14,285 | US$137K | 0.08% |
| Inspiremd Inc. | 148K | US$104K | 0.06% |
| Kalaris Therapeutics, Inc. | 25,000 | US$102K | 0.06% |
| Larimar Therapeutics, Inc. | 33,000 | US$101K | 0.06% |
| Context Therapeutics Inc. | 59,700 | US$33,068 | 0.02% |
| Gossamer Bio, Inc. | 70,000 | US$11,522 | <0.01% |
| Arrowhead Pharmaceuticals, Inc. | 0 | US$0 | 0.00% |
| Design Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Esperion Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Pmv Pharmaceuticals, Inc. | 0 | US$0 | 0.00% |